Moderna, Inc. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
Moderna, Inc. (MRNA) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $5.44 million as of 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2020-02-27
- 2019-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $5.44M.
- 2019-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $10.21M.
- 2019-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $15.19M.
- 2018-12-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $20.03M.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2019-09-30 | $5.44M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $10.21M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $15.19M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $20.03M 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |